Metaproterenol Sulfate

硫酸奥西那林

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMetaproterenol Sulfate
Drug Alias Name二羟苯基异丙氨基乙醇Orciprenaline sulphate硫酸间羟异丙肾上腺素AlotecMetaprel +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1973/07/31
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoehringer Ingelheim International Gmbh
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthma

Other Information

ATC CodeR03AB03R03CB03
Related LinksWikipediaDrugBankKEGG